Serum thymosin beta4 as a noninvasive biomarker in patients with nonalcoholic steatohepatitis.

What Was Tested

Researchers studied Thymosin Beta-4 (full length) in this human research study publication.

The aim of the study was to determine whether serum thymosin beta4 (Tβ4) can be a useful noninvasive biomarker to differentiate between nonalcoholic steatohepatitis (NASH) and nonalcoholic fatty liver (NAFL).

Who Took Part

The study group was 24 patients.

By PubMed's age tags, the people studied were adults, middle-aged adults and older adults, both men and women.

The study included 24 NAFL patients and 21 NASH patients.

The levels of Tβ4, 8-hydroxydeoxyguanosine acid (8-OhdG), liver function parameters, blood lipid, and glucose were detected in the venous blood of all patients.

How the Study Was Run

The NAFLD histological activity score (NAS) was examined in biopsy specimens from all patients.

Statistical analysis was performed in order to find differences between the two abovementioned groups.

In addition, receiver operator characteristic (ROC) analyses for alanine aminotransferase (ALT) and Tβ4 levels were performed in NAFL and NASH patients and the cut-off value was determined.

Associations between the variables were tested using correlation coefficient calculations.

What Was Measured

The subject headings attached to it are 8-Hydroxy-2'-Deoxyguanosine, Aspartate Aminotransferases, Biomarkers, Deoxyguanosine, Diagnosis, Differential, Liver and Liver Function Tests.

What This Means in Plain Language

This is a human research study of Thymosin Beta-4 (full length) in 24 patients.

With fewer than 40 people, it is a small study, so it is better read as an early signal for further research than as a settled answer.

Its findings take up roughly 5 sentences of the abstract and are left out here on purpose; the source paper is the place to read them.

The publication is from 2018 (Revista espanola de enfermedades digestivas), a journal based in Spain.

More context: the Thymosin Beta-4 (full length) compound page, all human trials.